Outlook Therapeutics Inc OTLKNasdaq
1.15USDClose on 08/10
At a glance
Outlook Therapeutics Inc sits in the ‘Resting’ stage of its cycle. It has moved -97.4% since its first surge signal on 2021-02-05, when the past-year gain stood at +121.3%.
- Since surge signal
- -97.4%
- First surge signal
- 2021-02-05
- Price at signal
- 43.6
- Past-year gain (at signal)
- +121.3%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.